Company

WuXi AppTec Reports 5.77% YOY Revenue Growth and 31.97% Increase in Net Profits for 2023Q1

CompanyLegal / IP

SMPA Suspends Procurement of Levornidazole by Warrant Pharmaceutical Over IP Concerns

CompanyDeals

Tot Biopharmaceutical Partners with Suzhou Smart Nuclide on Radioactive Drug Development

CompanyDrug

GSK’s Cervarix Receives Approval for Two-Dose Schedule in China for Ages 9 to 14

CompanyDrug

Everest Medicines’ Nefecon for IgAN Approved for Clinical Use in Hainan

CompanyDeals

Grand Pharmaceutical Group to Acquire Majority Stake in BlackSwan Vascular Inc. for $37.5 Million

CompanyDrug

Zelgen Biopharmaceuticals’ ZG2001 Receives US FDA Clinical Trial Approval for Pan-KRAS Inhibitor

CompanyDrug

Sichuan Biokin Pharmaceutical Gets NMPA Approval for Two Clinical Studies on Cancer Therapies

Company

YiChang HEC ChangJiang Pharmaceutical Reports 309.83% YOY Revenue Growth in 2022 Financials

Company

LianBio Appoints Pascal Qian as COO in Anticipation of Mavacamten Market Launch

CompanyDeals

Suzhou Basecare Medical and Qitan Tech Partner to Advance Nanopore Sequencing in PGT

CompanyDrug

Jiangsu Hengrui Pharmaceuticals’ Pyrotinib Gains NMPA Approval for HER2+ Breast Cancer Treatment